Lifecare AS

Lifecare AS

Health CarePharmaceuticals and Biotechnology
  • Price (NOK)1.92
  • Today's Change-0.055 / -2.79%
  • Shares traded6.85k
  • 1 Year change-55.20%
  • Beta--
Data delayed at least 15 minutes, as of Jun 09 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lifecare AS is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

  • Revenue in NOK (TTM)22.13m
  • Net income in NOK-17.48m
  • Incorporated2006
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Annexin Pharmaceuticals AB (publ)0.00-41.77m169.12m4.00--8.36-----0.2716-0.27160.000.12380.00-------123.07-111.82-144.39-132.67-----------20,689.000.00------21.89------
Bactiquant A/S19.53m-22.37m169.20m----7.50--8.66-0.7607-0.76070.66450.73060.51954.232.95---59.48-28.60-68.98-32.61-9.30---114.50-55.762.78-26.930.2479--48.20---4.66------
Bioextrax AB publ708.19k-20.37m171.44m----6.12--242.09-1.10-1.100.03631.090.0359--1.71---103.28---124.18---93.29---2,875.81------0.00--43.24---77.24------
Xintela AB0.00-66.30m184.02m-----------0.3372-0.33720.00-0.03430.000.00-----398.92-145.61---254.80-------14,755.580.4501-15.71---------11.20--54.98--
Moberg Pharma AB (publ)208.96k-16.45m198.54m----0.3622--950.12-1.88-1.880.023153.840.0004--0.0348---3.25---3.36--100.00---7,873.43------0.0091-----78.392.40------
Mendus AB (publ)0.00-142.71m199.08m33.00--0.4082-----0.7128-0.71280.002.420.00----0.00-21.18-21.38-22.98-23.23-------28,264.99---27.860.1429-------4.03------
Hamlet Pharma AB0.00-17.36m205.86m4.00--8.26-----0.1569-0.15690.000.34390.00-------63.13-88.40-84.36-115.77-----------226.20---------122.71------
Lifecare AS22.13m-17.48m232.20m----4.20--10.49-0.148-0.1480.18780.46880.4332--30.31---34.20-41.60-39.09-47.04-----78.96-147.96----0.00--1,284.20109.30-10.08------
Abliva AB31.29k-80.08m234.06m6.00--1.56--7,479.28-0.1162-0.11620.000040.14110.0003--0.0015,166.67-72.67-73.09-81.76-85.88-----255,896.80-78,072.63---37.560.00---79.472.8030.96---26.59--
Kancera AB0.00-58.52m234.08m7.00--2.53-----1.01-,023.47---78.970.00-------14.88------
Arctic Bioscience AS34.27m-34.02m248.11m----0.8298--7.24-1.40-1.401.4111.790.10240.70723.24---10.17---11.20--33.98---99.28--4.03--0.00--59.29--20.09------
ExpreS2ion Biotech Holding AB6.73m-132.32m252.06m28.00--2.40--37.48-3.36-3.360.1722.110.0548--5.19222,066.70-107.81-58.88-120.43-69.62-208.6925.33-1,967.53-394.75----0.0547---55.21-8.89-170.02--13.21--
Active Biotech AB publ0.00-54.69m257.24m11.00--11.09-----0.218-0.2180.000.08680.00-------132.45-33.26-185.84-77.75-------600.70----0.1513-------17.15------
Biovica International AB3.92m-92.72m262.58m33.00--1.72--67.06-2.81-2.810.11693.820.0216-1.678.55155,160.00-51.17-30.85-55.61-33.47152.10332.81-2,367.83-1,470.098.35-543.410.0592---1.5426.47-51.97------
SenzaGen AB42.17m-25.15m267.23m16.00--2.97--6.34-1.03-1.031.733.710.32924.244.56---19.63-25.18-24.68-27.9565.4478.89-59.64-214.331.86--0.0133--170.85105.0320.53---29.85--
Data as of Jun 09 2023. Currency figures normalised to Lifecare AS's reporting currency: Norwegian Krone NOK

Institutional shareholders

7.69%Per cent of shares held by top holders
HolderShares% Held
Nordea Investment Management AB (Norway)as of 28 Feb 20239.06m7.69%
Data from 28 Apr 2023 - 28 Apr 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.